Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting

International Journal of Pharmacy Practice

Volumn 10, Issue 4, 2002, Pages 267-272

  Mes, K ^a   den Berg, L T W de Jong van ^a   Van Grootheest, A C ^b  

^a Netherlands Pharmacovigilance Centre Lareb   (Netherlands)

^b Department of Social Pharmacy and Pharmacoepidemiology ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ARTICLE; ATTITUDE; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; EVALUATION; FEEDBACK SYSTEM; HUMAN; JOB PERFORMANCE; MEDICAL SOCIETY; NETHERLANDS; OUTCOMES RESEARCH; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SIDE EFFECT;

EID: 0036968027     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/096176702776868460     Document Type: Article

References (20)

1. Olsson S. National pharmacovigilance systems, country profiles and overview. 2nd ed Uppsala: WHO Uppsala Monitoring Centre; 1999.
2. Pharmacy ADR reporting now official. Pharm J 1997;258:582.
3. Koning GPH de. A regionalized spontaneous surveillance program for adverse drug reactions as a tool to improve pharmacotherapy [thesis]. Utrecht University, Faculty of Pharmaceutical Sciences; 1993.
4. Grootheest AC van, Puijenbroek EP van, Jong-van de Berg LTW de. Contribution of pharmacists to the reporting of adverse drug reactions. Pharmacoepidemiol Drug Safety 2002;11:205-10.
5. Grootheest AC van, Puijenbroek EP van. Artsen en apothekers kennen Lareb - is dat zo? [Physicians and Pharmacists know Lareb - is that true?]. Pharm Weekblad 2000;135:489-91.
6. Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmacists' attitude to adverse drug reaction reporting. Int J Pharm Pract 1999;7:92-9.
7. Sweis D, Wong ICK. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety 2000;2:165-72.
8. Green FG, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001;51:81-6.
9. Belton KJ, Lewis SC, Payne S, Rawlings MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995;39:223-6.
10. Eland EA, Belton KJ, Grootheest AC van, Meiners AP, Rawlins MD, Stricker BHCh. Attitudinal survey of voluntary reporting of drug reactions. Br J Clin Pharmacol 1999;48:623-7.
11. Fishbein M, Azjen I. Belief, attitude, intention and behavior: an introduction to theory and research. Reading: Addison-Wesley; 1975.
12. CIOMS Working Group IV. Benefit-risk balance for marketing drugs: safety signals. CIOMS: Geneva; 1998.
13. Vries CS de. Collaboration in healthcare, the tango to drug safety [thesis]. University of Groningen; 1998.
14. Whittlesea CMC, Walker R. An adverse drug reaction reporting scheme for community pharmacists. Int J Pharm Pract 1996;4:228-34.
15. Mill JWF van. Pharmaceutical care, the future in pharmacy [thesis]. University of Groningen; 1999.
16. Emerson AE, Martin RM, Tomlin M, Mann RD. Prospective cohort study of adverse events monitored by hospital pharmacists. Pharmacoepidemiol Drug Safety 2001;10:95-103.
17. Het melden van bijwerkingen, de rol van de ziekenhuisapotheker [The reporting of ADRs, the role of the hospital pharmacist]. Lareb's-Hertogenbosch; 2001.
18. Reebye RN, Avery AJ, Bosch WJHM van den, Aslam M, Nijholt A, Bij A van der. Exploring community pharmacists' perception of their professional relationship with physicians in Canada and the Netherlands. Int J Pharm Pract 1999;7:149-58.
19. Sinclair HK, Bond CM, Hannaford PC. Pharmacovigilance of over-the-counter products based in community pharmacy; a feasible option? Pharmacoepiol Drug Safety 1999;8:479-91.
20. Meyboom RHB. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Safety 1997;16:374-89.